Transaction · 0001193125-26-361184

Bair Teresa Brophy

Bair Teresa Brophy, CLO, reported an open-market or private sale at Kura Oncology, Inc. involving 31487.000000 shares for an estimated $397680.81. Reported holdings after the transaction were 195444.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCLO
KURAKura Oncology, Inc.
Trade date
Aug 19, 2026
Filing date
Aug 21, 2026
View on SEC Insider profile
Disclosed value-$397kShares × reported price
Shares traded31.4k$12.63 per share
Holdings after195kDirect
% of reported position traded13.88%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 226,931 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

KURA price since this filing

Daily closing prices, with the filing date and available return windows
KURA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -10.2%1w ago -16.4%1d ago +3.7%
Returns since7d +6.5%30d -1.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-361184
Common Stock
Transaction date
Aug 19, 2026
Filed Aug 21, 2026, 08:30 PM · 2d delay
Shares
31,487 sh
$12.63 per share
Estimated value
-$397k
Computed from shares × price
Holdings after
195,444 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Legal Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The shares sold were acquired by the Reporting Person upon vesting of restricted stock units during the period from January 26, 2024 through January 26, 2026. The sales reported herein were effected p…

  2. F2

    This transaction was executed in multiple trades at prices ranging from $12.44 to $12.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to p…

Original filing · 0001193125-26-361184
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

KURA